Dental Restoration Market

Dental amalgam has been banned for most treatment in the European Union since 1 January 2025 under Regulation (EU) 2024/1849, and on 7 November 2025 the Minamata Convention agreed a global phase-out of dental amalgam by 2034, the UN Environment Programme (UNEP) announced. The dental restoration market covers the materials and prefabricated products dentists and laboratories use to rebuild damaged teeth: direct composite resins, glass ionomers and compomers, bonding agents and luting cements, ceramic CAD/CAM blocks and discs, 3D-printing restorative resins, metal and porcelain-fused-to-metal alloys, prefabricated crowns and amalgam. Douglas Insights sizes it at USD 8.40 billion in 2025, about 1.20 billion tooth restorations at an average USD 7.00 of material each, rising to USD 8.78 billion in 2026 and USD 13.11 billion in 2035, a 4.55% compound annual growth rate (CAGR). The study sits beside our Zirconia Dental Indirect Restorations Material Market, Dental Implants Market and Dental Equipment Market reports, and every figure follows the Douglas Insights research methodology.

Which dental restoration material earns the most: composites, ceramics or cements?

Direct composite resins earn the most, 30.0% of 2025 value or about USD 2.52 billion, Douglas Insights estimates. 3D-printing restorative resins grow fastest, 11.5% a year, from USD 420 million to USD 1.25 billion by 2035.

Composites lead because they are the default filling in North America, Europe, Japan and urban China, and a single tooth-coloured filling uses only about USD 2 to USD 4 of resin, a Douglas Insights estimate, so volume rather than price carries the segment. Bulk-fill composites, placed in 4 mm layers instead of 2 mm, save chair time and take a rising share of the 3.9% yearly growth. Ceramic CAD/CAM blocks and discs, USD 2.02 billion, are the second engine: monolithic zirconia and lithium disilicate crowns milled in laboratories or at the chair replace porcelain-fused-to-metal crowns, which is why metal alloys shrink 2.0% a year to USD 549 million.

Glass ionomers and compomers grow 5.4% a year to USD 1.28 billion because they are the main low-cost substitute for amalgam in public dental programmes, children and older patients. Dental amalgam falls from USD 168 million to about USD 9 million, a 25% yearly decline, as the EU ban and the 2034 Minamata deadline take effect. Segment values for 2035 sum to USD 13.11 billion, 0.05% above the headline.

How does dental restoration demand split between direct fillings, indirect crowns and new digital workflows?

Direct restorations placed in one visit take about 59% of 2025 dental restoration value, roughly USD 4.97 billion, while indirect crowns, bridges, inlays, onlays and veneers take about 41%, USD 3.43 billion, Douglas Insights estimates.

By count the split is far more lopsided. Of the 1.20 billion restorations in our 2025 base, about 1.05 billion are direct fillings and only about 150 million are indirect units, all Douglas Insights estimates; an indirect unit carries about USD 23 of material against about USD 4.70 for a direct filling once bonding and cement are shared out. That gap is why the shift from fillings to crowns in ageing populations raises value faster than volume.

Digital workflows sit inside both groups. Intraoral scans feed chairside milling of ceramic blocks and, increasingly, 3D printing of permanent crowns in hybrid resin-ceramic materials. The US Food and Drug Administration (FDA) cleared Shining 3D’s LumiCera resin “for fabricating permanent single crowns, permanent inlays and onlays, veneers, bridges” on 21 January 2026 under 510(k) K260170, and MMTech’s Smart Print Bio Vitality for crowns, veneers, inlays and onlays on 23 April 2026 under 510(k) K260152, FDA records show.

What drives dental restoration volumes: untreated caries, ageing patients or chairside digital dentistry?

Revenue rises 4.55% a year in our base case: restorations add 2.60% and material value per restoration 1.90%. Four drivers add 3.40 gross points to volume before 0.80 points of restraints, Douglas Insights estimates.

Untreated caries and wider access: 1.20 points

Untreated tooth decay is the largest pool of unmet demand. Oral diseases affect “nearly 3.7 billion people” and untreated caries of permanent teeth is the most common health condition in the Global Burden of Disease 2021 study, the World Health Organization (WHO) oral health fact sheet of 17 March 2025 states. If only 1% of that 3.7 billion receives one extra filling a year, volume rises by 37 million restorations, about 3.1% of our 1.20 billion base, a Douglas Insights estimate; we credit a more cautious 1.20 points, concentrated in China, India, Southeast Asia and Latin America, where dentist numbers and insurance coverage are rising from low levels.

Ageing patients keep more teeth: 0.90 points

Older patients who keep their natural teeth need crowns, onlays and replacement fillings rather than dentures, which adds 0.90 points. Spending confirms the shift in the largest market: US dental spending reached USD 189 billion in 2024, 3.6% of all health spending and up USD 7 billion or 4% after inflation, with government spending up 9%, the American Dental Association Health Policy Institute (ADA HPI) analysis of national health expenditure data released in January 2026 shows. Each replacement crown on a heavily filled molar carries about five times the material value of the filling it replaces, a Douglas Insights estimate.

Chairside digital dentistry and 3D printing: 0.80 points

Digital dentistry adds 0.80 points by making single-visit crowns cheaper to produce. Straumann Group, whose portfolio spans implants, intraoral scanners and CAD/CAM materials, grew 2025 revenue 8.9% organically to CHF 2,605.4 million and reported “very solid sales momentum” for its SIRIOS X3 scanner, its results of 18 February 2026 show. It accelerated to 9.2% organic growth and CHF 667.1 million in the third quarter of 2026, with more than 20,000 active users on its Straumann AXS digital platform, its trading update of 28 October 2026 states.

Insurance and public programmes: 0.50 points

Public cover adds the last 0.50 points. US government dental spending rose 9% in 2024, faster than private insurance at 2.3% or out-of-pocket at 3.3%, the same ADA HPI data show. Summed, 1.20 + 0.90 + 0.80 + 0.50 = 3.40 points; after 0.80 points of restraints the volume leg is 2.60%, and 1.026 x 1.019 gives the 4.55% revenue rate.

What holds back dental restoration sales: dealer destocking, weak US practices or prevention?

Three restraints remove 0.80 points a year: weak patient traffic and distributor destocking take 0.40 points, fluoride prevention and sealants 0.20 points, and dentist and hygienist shortages 0.20 points, Douglas Insights estimates.

Destocking is visible in 2026 filings. Solventum’s Dental Solutions sales fell 7.4% organically to USD 317 million in the third quarter of 2026, from USD 340 million, its results of 5 November 2026 show, as advance orders placed in the second quarter ahead of a systems change reversed. Dentsply Sirona’s third-quarter 2026 net sales fell 7.6% to USD 836 million, and its Essential Dental Solutions segment, which holds its restorative, endodontic and preventive consumables, sold USD 343 million, its results of 5 November 2026 state; it now guides 2026 net sales to about USD 3.5 billion against USD 3.68 billion in 2025.

Prevention is a slow brake in high-income countries, where fluoride toothpaste, water fluoridation and sealants reduce first-time cavities in children, a Douglas Insights estimate. Workforce limits cap how many restorations clinics can place: a material sale needs chair time, so practices short of dentists or assistants defer elective crowns. Coltene’s 2025 net sales fell 4.0% in Swiss francs to CHF 240.0 million, flat at -0.2% in local currencies, its results of 6 March 2026 show, a reminder that smaller consumables makers feel weak practice traffic first.

Which region buys the most dental restoration products: North America, Europe or Asia Pacific?

North America buys the most dental restoration products, about USD 2.86 billion or 34.0% of 2025 value. Asia Pacific grows fastest, at 6.0% a year, and nearly draws level with North America at about USD 4.06 billion by 2035.

North America leads because US dentists place mostly composites and monolithic zirconia crowns, and the country spent USD 189 billion on dental care in 2024, the ADA HPI reports. Growth of 3.9% a year rests on ageing patients and Medicaid and Medicare Advantage dental benefits. Europe, USD 2.52 billion, grows 3.7% a year to USD 3.62 billion: the amalgam ban lifts composite and glass ionomer demand, but patient numbers are flat. Straumann’s EMEA sales grew 11.2% organically in 2025, its February 2026 release shows, and 10.5% in the third quarter of 2026, its October 2026 update shows, which signals healthy laboratory and clinic activity.

Asia Pacific, USD 2.27 billion, grows 6.0% a year as Chinese, Indian and Southeast Asian clinics add dentists and digital laboratories. Straumann’s Asia Pacific sales rose 10.3% organically in the third quarter of 2026, its October 2026 update shows. Latin America, USD 462 million, grows 5.0%, and Straumann’s region grew 18.3% organically in 2025, its full-year release states. The Middle East and Africa, USD 294 million, grows 5.6% from private clinics in the Gulf. Regional values sum to USD 13.13 billion in 2035, 0.19% above the headline.

Which companies lead the dental restoration market, and how concentrated is supply?

Ivoclar leads dental restoration supply with about 9.0% of 2025 value, a Douglas Insights estimate, ahead of Solventum at about 7.5% and Dentsply Sirona at about 7.0%. The ten largest suppliers hold about 55%.

Solventum, spun off from 3M, sold USD 1.35 billion of dental products in 2025, up 3.3% organically, with fourth-quarter dental sales up 5.9%, its results of 26 February 2026 show; restorative composites and cements are slightly under half of that by our estimate, giving 7.5% of the market. Dentsply Sirona’s Essential Dental Solutions segment grew 1.1% to USD 1.47 billion in 2025 while total sales fell 3.0% to USD 3.68 billion, its full-year release of 26 February 2026 shows.

Envista grew third-quarter 2026 sales 3.2% to USD 691.5 million, with Equipment and Consumables, home of Kerr restoratives, up 4.1% on a core basis, its results of 4 November 2026 state. Mitsui Chemicals’ Life and Healthcare Solutions segment, which includes Kulzer, grew revenue to JPY 259.1 billion in the year to March 2026 and booked a JPY 4.0 billion restructuring-related loss involving Kulzer, its results of 13 May 2026 show. Shofu, VOCO, Septodont and hundreds of Chinese and Korean zirconia disc makers share the remaining 45% with dental laboratory groups.

How much material does one dental restoration use, and why is the value per restoration rising?

Material value averages USD 7.00 per dental restoration in 2025, Douglas Insights estimates, from about USD 1.50 for an amalgam filling to USD 35 for a lithium disilicate crown block, rising 1.90% a year to USD 8.45 by 2035.

Prices sit in clear bands, all Douglas Insights estimates at the manufacturer’s selling price: about USD 1.50 of alloy for an amalgam filling, USD 2.50 for a glass ionomer filling, USD 3.50 for a composite filling with its share of adhesive, USD 12 for a porcelain-fused-to-metal crown’s alloy and porcelain, USD 18 for a zirconia crown cut from a disc, USD 22 for a 3D-printed permanent crown and USD 35 for a pressed or milled lithium disilicate crown. Mix sets the average: each point of indirect share gained from fillings lifts the average by about USD 0.18.

What patients pay is far higher, because the material is a small part of the fee. From 1 April 2026 an NHS England Band 2 course of treatment, which covers fillings, costs GBP 76.60 and a Band 3 course, which covers crowns, bridges and dentures, GBP 332.10, the NHS Business Services Authority charges page shows. Our material value of USD 7.00 is under 10% of the cheaper band, which is why dentists pick materials on handling and longevity rather than price, and why makers can pass through 1% to 2% a year on established composites.

What if prevention wins or digital crowns spread faster: how large is the dental restoration market in 2035?

The dental restoration market ends 2035 between USD 10.25 billion and USD 15.47 billion across three cases, around a USD 13.11 billion base. Restoration volume in Asia and the indirect share set most of the spread.

In the slower case Western patient traffic stays weak, Chinese and Indian access improves slowly and price competition from Asian zirconia and composite makers holds the value leg under 1%, a Douglas Insights scenario. In the faster case 3D-printed permanent crowns cut the cost of indirect work so that the indirect share of restorations rises from about 12.5% to about 16% by 2035, and Asian clinics add volume faster than expected. One extra point of yearly revenue growth adds about USD 1.31 billion to 2035 value.

Live signals point between the base and slower cases for 2026 and toward the base afterwards. Straumann confirmed its 2026 outlook of high single-digit organic growth in its update of 28 October 2026, Envista guides 3.75% to 4.25% core growth in its release of 4 November 2026, while Dentsply Sirona expects 2026 sales of about USD 3.5 billion, about 5% below 2025, its results of 5 November 2026 show.

Which rules shape dental restoration materials, from the EU amalgam ban to the Minamata 2034 deadline?

Three rule sets shape dental restoration demand: the EU amalgam ban in force since 1 January 2025, the Minamata Convention’s 2034 global phase-out, and device clearance under FDA 510(k) and the EU Medical Device Regulation.

The EU rule is the most immediate. Article 10(2a) of the mercury regulation, as amended by Regulation (EU) 2024/1849 of 13 June 2024, states that from 1 January 2025 “dental amalgam shall not be used for dental treatment in the Union, except when deemed strictly necessary by the dental practitioner based on the specific medical needs of the patient”. Member States where amalgam was the only material publicly reimbursed at a rate of at least 90% could keep using it until 30 June 2026, exports have been banned since 1 January 2025, and manufacture and import have been banned since 1 July 2026. The Commission must review the medical-needs exception by 31 December 2029.

The global layer followed. Parties to the Minamata Convention meeting in Geneva from 3 to 7 November 2025 adopted amendments to Annex A “establishing a global phase-out of dental amalgam by 2034”, the UNEP release of 7 November 2025 states. For new resin materials the gate is clearance: in the United States the permanent 3D-printing resins cleared in January and April 2026 went through 510(k) premarket notification, as the FDA records for K260170 show, while EU makers must certify under the Medical Device Regulation.

Douglas Exclusive: the Amalgam Switch Ledger

The Amalgam Switch Ledger is a Douglas Insights model built from 12 inputs: 2 regulatory texts, 1 WHO fact sheet, 1 ADA dataset, 1 NHS price schedule, 2 FDA clearances and 5 company filings. It values amalgam replacement.

The finding, a Douglas Insights estimate: about 112 million amalgam fillings were still placed worldwide in 2025, worth USD 168 million at about USD 1.50 each, most of them in South and Southeast Asia, Africa and public programmes in Eastern Europe. Replacing all of them with composites at USD 3.50 each would add about USD 224 million of value, and replacing them with glass ionomers at USD 2.50 about USD 112 million; the ledger assumes a 60:40 split, which adds about USD 179 million of value by 2034 without a single extra tooth being treated.

That conversion explains about 0.20 points of the 1.90-point value per restoration leg. The rest comes from crowns moving from metal-based to all-ceramic and printed materials, so the ledger shows that the amalgam phase-out is a meaningful but secondary source of growth, and that glass ionomer makers such as GC gain most where public programmes buy on price.

How does the methodology turn 1.20 billion restorations into USD 8.40 billion?

Our methodology multiplies 1.20 billion tooth restorations by an average USD 7.00 of material to reach USD 8.40 billion in 2025, then grows volume 2.60% and value per restoration 1.90% a year to 2035.

The model covers 8 material segments, 2 restoration types and 5 regions, using 76 data points, 24 sourced and 52 modelled. Volume starts from Douglas Insights estimates of dentists, patient visits and restorations per visit by region, checked against WHO disease burden and ADA HPI spending data; material values come from supplier list prices and segment revenue. Arithmetic: 1.20 billion x USD 7.00 = USD 8.40 billion; 2026: USD 8.40 billion x 1.04549 = USD 8.78 billion; 2035: USD 8.40 billion x 1.04549^10 = USD 13.11 billion.

Two cross-checks agree. First, Solventum’s and Dentsply Sirona’s restorative consumables, which we put at about 47% of Solventum’s USD 1.35 billion dental segment and 40% of Dentsply Sirona’s USD 1.47 billion Essential Dental Solutions segment, sum to about USD 1.22 billion, 14.5% of our total, consistent with our 7.5% and 7.0% shares. Second, Coltene’s Dental Preservation category, 26.7% of its CHF 240.0 million sales or about USD 77 million, matches its 0.9% share. AI tools help draft the text and automated checks test the arithmetic and links; the Douglas Insights research desk chooses the sources, builds the model and approves publication, as our editorial standards explain.

Sources

1. UNEP Minamata Convention COP-6 agrees end to use of dental amalgam by 2034 (2025)
2. EUR-Lex Regulation (EU) 2024/1849 on mercury (2024)
3. Straumann Group Straumann Group full-year 2025 results (2026)
4. Straumann Group (wire) Straumann Group third quarter 2026 update (2026)
5. Dentsply Sirona (SEC) Dentsply Sirona third quarter 2026 results (2026)
6. Dentsply Sirona Dentsply Sirona fourth quarter and full-year 2025 results (2026)
7. Solventum Solventum full-year 2025 results (2026)
8. Solventum (SEC) Solventum third quarter 2026 results (2026)
9. Envista (SEC) Envista third quarter 2026 results (2026)
10. Coltene Coltene 2025 results (2026)
11. Mitsui Chemicals Mitsui Chemicals FY2025 results (2026)
12. World Health Organization Oral health fact sheet (2025)
13. ADA Health Policy Institute National dental expenses (2026)
14. NHS Business Services Authority NHS dental charges (2026)
15. US FDA 510(k) K260170 LumiCera (2026)

What counts in the dental restoration study, and what is excluded?

The study counts restorative materials and prefabricated restorations sold to dentists and dental laboratories, valued at the manufacturer’s selling price. Laboratory labour, dentist fees, implants, scanners, mills, printers and orthodontic products are excluded.

The study splits value by 8 material segments, 2 restoration types (direct and indirect) and 5 regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Related equipment and implant markets appear in our Dental Equipment Market, Dental Implants Market and 3D CAM Software Market reports.